Literature DB >> 20644175

Dendritic cells continue to capture and present antigens after maturation in vivo.

Scott B Drutman1, E Sergio Trombetta.   

Abstract

Dendritic cell (DC) maturation is critical for the regulation of T cell responses. The downregulation of endocytosis on maturation is considered a key adaptation that dissociates prior Ag capture by DCs from subsequent T cell engagement. To study the dynamics of Ag capture and presentation in situ, we studied the capacity for Ag uptake by DCs matured in their natural tissue environment. We found that after maturation in vivo, mouse DCs retained a robust capacity to capture soluble Ags. Furthermore, Ags internalized by mature DCs were efficiently presented on MHC class II and cross-presented on MHC class I. These results suggest that under inflammatory conditions, mature DCs may contribute to T cell stimulation without exclusively relying on prior exposure to Ags as immature DC precursors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20644175      PMCID: PMC2928255          DOI: 10.4049/jimmunol.1000642

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

Review 1.  Antigen presentation and T cell stimulation by dendritic cells.

Authors:  Pierre Guermonprez; Jenny Valladeau; Laurence Zitvogel; Clotilde Théry; Sebastian Amigorena
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 3.  Dendritic cells as sensors of infection.

Authors:  C Reis e Sousa
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

Review 4.  Mechanisms of phagocytosis in macrophages.

Authors:  A Aderem; D M Underhill
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

5.  Developmental regulation of MHC class II transport in mouse dendritic cells.

Authors:  P Pierre; S J Turley; E Gatti; M Hull; J Meltzer; A Mirza; K Inaba; R M Steinman; I Mellman
Journal:  Nature       Date:  1997-08-21       Impact factor: 49.962

6.  Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

Authors:  P Blanco; A K Palucka; M Gill; V Pascual; J Banchereau
Journal:  Science       Date:  2001-11-16       Impact factor: 47.728

7.  Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs.

Authors:  I Frank; M Piatak; H Stoessel; N Romani; D Bonnyay; J D Lifson; M Pope
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures.

Authors:  C Winzler; P Rovere; M Rescigno; F Granucci; G Penna; L Adorini; V S Zimmermann; J Davoust; P Ricciardi-Castagnoli
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

9.  Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.

Authors:  A Regnault; D Lankar; V Lacabanne; A Rodriguez; C Théry; M Rescigno; T Saito; S Verbeek; C Bonnerot; P Ricciardi-Castagnoli; S Amigorena
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

10.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.

Authors:  F Sallusto; M Cella; C Danieli; A Lanzavecchia
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  40 in total

1.  CD14 controls the LPS-induced endocytosis of Toll-like receptor 4.

Authors:  Ivan Zanoni; Renato Ostuni; Lorri R Marek; Simona Barresi; Roman Barbalat; Gregory M Barton; Francesca Granucci; Jonathan C Kagan
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

Review 2.  From optical bench to cageside: intravital microscopy on the long road to rational vaccine design.

Authors:  Heather D Hickman; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 3.  The ins and outs of MHC class II-mediated antigen processing and presentation.

Authors:  Paul A Roche; Kazuyuki Furuta
Journal:  Nat Rev Immunol       Date:  2015-02-27       Impact factor: 53.106

4.  A novel cancer therapeutic using thrombospondin 1 in dendritic cells.

Authors:  Tzu-Yang Weng; Shih-Shien Huang; Meng-Chi Yen; Chi-Chen Lin; Yi-Ling Chen; Chiu-Mei Lin; Wei-Ching Chen; Chih-Yang Wang; Jang-Yang Chang; Ming-Derg Lai
Journal:  Mol Ther       Date:  2013-10-15       Impact factor: 11.454

5.  Inflammatory spleen monocytes can upregulate CD11c expression without converting into dendritic cells.

Authors:  Scott B Drutman; Julia C Kendall; E Sergio Trombetta
Journal:  J Immunol       Date:  2012-03-21       Impact factor: 5.422

Review 6.  Trial watch: DNA-based vaccines for oncological indications.

Authors:  Stefano Pierini; Renzo Perales-Linares; Mireia Uribe-Herranz; Jonathan G Pol; Laurence Zitvogel; Guido Kroemer; Andrea Facciabene; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-11-20       Impact factor: 8.110

Review 7.  Co-ordination of incoming and outgoing traffic in antigen-presenting cells by pattern recognition receptors and T cells.

Authors:  Priyanka Nair; Derk Amsen; J Magarian Blander
Journal:  Traffic       Date:  2011-08-15       Impact factor: 6.215

Review 8.  Regulation of the Cell Biology of Antigen Cross-Presentation.

Authors:  J Magarian Blander
Journal:  Annu Rev Immunol       Date:  2018-02-28       Impact factor: 28.527

9.  Mycobacterium bovis DNA detection in colostrum as a potential indicator of vaccination effectiveness against bovine tuberculosis.

Authors:  Sara E Herrera-Rodríguez; María Alejandra Gordiano-Hidalgo; Gonzálo López-Rincón; Luis Bojorquez-Narváez; Francisco Javier Padilla-Ramírez; Ana Laura Pereira-Suárez; Mario Alberto Flores-Valdez; Ciro Estrada-Chávez
Journal:  Clin Vaccine Immunol       Date:  2013-02-20

10.  Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide.

Authors:  Jake Y Henry; Marie-Christine Labarthe; Brendan Meyer; Prokar Dasgupta; Angus G Dalgleish; Christine Galustian
Journal:  Immunology       Date:  2013-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.